AAAAAA
Results:
1-12
|
Results: 12
Authors:
Brechtbuehl, K
Whalley, SA
Dusheiko, GM
Saunders, NA
Citation: K. Brechtbuehl et al., A rapid real-time quantitative polymerase chain reaction for hepatitis B virus, J VIROL MET, 93(1-2), 2001, pp. 105-113
Authors:
Whalley, SA
Brown, D
Teo, CG
Dusheiko, GM
Saunders, NA
Citation: Sa. Whalley et al., Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler, J CLIN MICR, 39(4), 2001, pp. 1456-1459
Authors:
Whalley, SA
Murray, JM
Brown, D
Webster, GJM
Emery, VC
Dusheiko, GM
Perelson, AS
Citation: Sa. Whalley et al., Kinetics of acute hepatitis B virus infection in humans, J EXP MED, 193(7), 2001, pp. 847-853
Authors:
Webster, GJM
Reignat, S
Maini, MK
Whalley, SA
Ogg, GS
King, A
Brown, D
Amlot, PL
Williams, R
Vergani, D
Dusheiko, GM
Bertoletti, A
Citation: Gjm. Webster et al., Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms, HEPATOLOGY, 32(5), 2000, pp. 1117-1124
Authors:
Webster, GJM
Hallett, R
Whalley, SA
Meltzer, M
Balogun, K
Brown, D
Farrington, CP
Sharma, S
Hamilton, G
Farrow, SC
Ramsay, ME
Teo, CG
Dusheiko, GM
Citation: Gjm. Webster et al., Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy, LANCET, 356(9227), 2000, pp. 379-384
Authors:
Heathcote, EJ
Shiffman, ML
Cooksley, WGE
Dusheiko, GM
Lee, SS
Balart, L
Reindollar, R
Reddy, RK
Wright, TL
Lin, A
Hoffman, J
De Pamphilis, J
Citation: Ej. Heathcote et al., Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis, N ENG J MED, 343(23), 2000, pp. 1673-1680
Authors:
Khakoo, SI
Ling, R
Scott, I
Dodi, AI
Harrison, TJ
Dusheiko, GM
Madrigal, JA
Citation: Si. Khakoo et al., Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg,anti-HBe positive individuals, GUT, 47(1), 2000, pp. 137-143
Authors:
Keeffe, EB
Dusheiko, GM
James, SP
Mullen, KD
Everson, GT
Pimstone, NR
Donovan, J
Albert, D
Citation: Eb. Keeffe et al., Utility of hepatitis C virus serotypes in predicting response to treatmentof chronic hepatitis C, CYTOK CELL, 5(4), 1999, pp. 207-210
Authors:
Keeffe, EB
Dusheiko, GM
Tong, MJ
Hollinger, FB
Heathcote, EJL
McHutchison, J
Albert, D
Citation: Eb. Keeffe et al., Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C, CYTOK CELL, 5(4), 1999, pp. 211-216
Authors:
Papatheodoridis, GV
Patch, D
Dusheiko, GM
Burroughs, AK
Citation: Gv. Papatheodoridis et al., The outcome of hepatitis C virus infection after liver transplantation - is it influenced by the type of immunosuppression?, J HEPATOL, 30(4), 1999, pp. 731-738
Authors:
Sathar, MA
Soni, PN
Pegoraro, R
Simmonds, P
Smith, DB
Dhillon, AP
Dusheiko, GM
Citation: Ma. Sathar et al., A new variant of GB virus C/hepatitis G virus (GBV-C/HGV) from South Africa, VIRUS RES, 64(2), 1999, pp. 151-160
Authors:
Khakoo, S
Glue, P
Grellier, L
Wells, B
Bell, A
Dash, C
Murray-Lyon, I
Lypnyj, D
Flannery, B
Walters, K
Dusheiko, GM
Citation: S. Khakoo et al., Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions, BR J CL PH, 46(6), 1998, pp. 563-570
Risultati:
1-12
|